A pragmatic approach to amblyopia diagnosis: evidence into practice

Webber, Ann; Camuglia, Jayne E

doi:10.1111/cxo.12662

Cited by 5 publications

(2 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While amblyopia (poor vision from abnormal vision development) is a leading cause of reduced vision in children, the diagnosis of amblyopia needs both the presence of an amblyogenic factor and the absence of underlying pathology or structural anomalies. 12 Viewing through enlarged pupils from cycloplegic agents greatly assists the careful inspection of ocular media and posterior pole.…”

Section: Cycloplegia For Refraction and Mydriasis For Fundus Examinationmentioning

confidence: 99%

Practical use and prescription of ocular medications in children and infants

Webber

Sharwood

2021

Clinical and Experimental Optometry

Self Cite

View full text Add to dashboard Cite

Optometrists in Australia employ ophthalmic medicines in their paediatric practice to assist clinical diagnosis and to treat ocular conditions. Prior to employing ocular medicines or initiating treatment, it is important to consider the risks versus benefits of ophthalmic medicines and determine the minimum dose required to safely achieve a diagnostic or therapeutic benefit. Instilling drops in infants and young children may require techniques that do not depend on full cooperation, particularly to maintain appropriate dosing and limit the rate of elimination from the eye. Diagnostic cycloplegic agents are highly recommended for the accurate determination of refractive error in infants and young children. Topical atropine is commonly prescribed in paediatric optometry practice in highly variable concentrations. 1% atropine eye drops are used for pharmacological penalisation in management of amblyopia, and, increasingly, low concentration (< 0.1%) atropine is used to manage the progression of childhood myopia. Doses of topical ocular medicines to treat inflammation, infection or glaucoma are generally identical to those use in adults; however, there is potential for increased ocular and systemic side effects with certain medications. It is, therefore, timely to present, summarise and comment on the use of ophthalmic diagnostic and therapeutic agents in children and reference where practitioners can look for more detailed information. The perspective is set in the Australian context of a collaborative approach between paediatric optometry and ophthalmology eye care practitioners for delivery of best practice care in infants and young children. Inclusion of the more complex spectrum of paediatric eye disease in a tertiary ophthalmological setting is provided to build practitioner knowledge of treatment regimens their patients may be using, even though management of these conditions lies outside their scope of practice.

show abstract

Section: Cycloplegia For Refraction and Mydriasis For Fundus Examinationmentioning

confidence: 99%